Search results
Results from the WOW.Com Content Network
As cases rise around the world, U.S. health officials are warning Americans about dengue fever, a potentially fatal disease carried by mosquitoes. The disease, which includes symptoms such as a ...
FARE has developed research infrastructure to support advances in the understanding, management, treatment and prevention of food allergy. Initiated in 2015 and expanded in 2020, the FARE Clinical Network [10] is a coalition of academic, research, and clinical care centers specializing in food allergy.
Severe dengue can develop suddenly, sometimes after a few days as the fever subsides. [24] Leakage of plasma from the capillaries results in extreme low blood pressure and hypovolemic shock; Patients with severe plasma leakage may have fluid accumulation in the lungs or abdomen, insufficient protein in the blood, or thickening of the blood ...
Dengue infection, being of viral origin, lacks a specific treatment, focusing rather on relieving symptoms and managing its possible complications. For this, paracetamol is the recommended medication as an antipyretic and analgesic, while the use of NSAIDs such as ibuprofen , aspirin or naproxen is discouraged due to their potential to worsen ...
A pill for dengue fever developed by Johnson & Johnson appeared to protect against a form of the virus in a handful of patients in a small human challenge trial in the United States, according to ...
According to the U.S. Centers for Disease Control and Prevention, the best way to prevent dengue is to avoid mosquito bites with an Environmental Protection Agency-registered insect repellent like ...
Treatment of acute dengue is supportive, using either oral or intravenous rehydration for mild or moderate disease, and intravenous fluids and blood transfusion for more severe cases. The incidence of dengue fever has increased dramatically since the 1960s, with around 50–100 million people infected yearly. Early descriptions of the condition ...
The FDA has granted Fast Track Designation for Atea Pharmaceuticals Inc's (NASDAQ: AVIR) AT-752 for treating dengue virus infection. AT-752, a novel, orally administered direct-acting antiviral ...